Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database
Adaptive Biotechnologies Corp. on Thursday launched ImmuneCODE with Microsoft to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in real time based on de-identified data generated from thousands of COVID-19 blood samples from patients around the globe. The open database contains detailed information on the extraordinarily diverse set of T cells shown to specifically recognize unique features of the COVID-19 virus, called antigens, with unprecedented speed and scale.